Schwerin Boyle Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $275K | Hold |
|
|||||
|
2024
Q4 | $255K | Hold |
|
|||||
|
2024
Q3 | $233K | Sell |
|
|||||
|
2024
Q2 | $227K | Hold |
|
|||||
|
2024
Q1 | $296K | Hold |
|
|||||
|
2023
Q4 | $280K | Hold |
|
|||||
|
2023
Q3 | $317K | Sell |
|
|||||
|
2023
Q2 | $366K | Sell |
|
|||||
|
2023
Q1 | $643K | Buy |
|
|||||
|
2022
Q4 | $610K | Hold |
|
|||||
|
2022
Q3 | $602K | Hold |
|
|||||
|
2022
Q2 | $653K | Hold |
|
|||||
|
2022
Q1 | $619K | Hold |
|
|||||
|
2021
Q4 | $528K | Sell |
|
|||||
|
2021
Q3 | $513K | Hold |
|
|||||
|
2021
Q2 | $580K | Buy |
|
|||||
|
2021
Q1 | $309K | Hold |
|
|||||
|
2020
Q4 | $304K | Buy |
|